Phase Ia/Ib dose escalation and dose expansion study of IBI360 monotherapy in advanced or metastatic Solid Tumors.
This is an open label Phase Ia/Ib trial to evaluate safety, tolerability, pharmacokinetics and preliminary efficacy of IBI360 monotherapy in Advanced or Metastatic Solid Tumors